Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic ...
Strategy (MSTR) is reportedly offering investors better terms for its $2B issue of convertible debt, lowering the conversion ...
Investors reacted to the news by selling off Hyperfine shares, concerned about the potential dilution of existing stock. The capital raised from this offering is slated for working capital and ...
Dividend investing has long rewarded patient investors. Data shows that from 1998 to 2018, high-yield dividend stocks posted ...
Zurn Elkay will not sell any common stock in the offering and will not receive any proceeds from the sale of the shares of common stock by the selling stockholder in this offering. Evercore ISI is ...